Premium
Kymera Therapeutics Inc (KYMR)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-26 | Dr. Jeremy G. ChadwickCOO | -13,13k | 1,06M | Automatic Disposition | 79,39 - 82,08 | 1,97k | -86,97% |
| 2026-05-26 | Dr. Jeremy G. ChadwickCOO | -4,05k | 317,92k | Vente | 78,36 - 79,17 | 1,97k | -67,32% |
| 2026-05-19 | Dr. Pamela EspositoIndependent Director | 1 000,00 | 31,20k | Derivative Exercise and Retained Stock | 31,20 | 1 000,00 | - |
| 2026-05-18 | Mr. Bruce N. JacobsCFO | 15,00k | 31,20k | Derivative Exercise and Retained Stock | 2,08 | 199,52k | 8,13% |
| 2026-05-11 | Ms. Elena H. RidloffIndependent Director | -3,00k | 167,40k | Derivative Exercise and Sale | 31,20 - 87,00 | 0,00 | - |
| 2026-04-29 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 2,37M | Derivative Exercise and Sale | 2,08 - 82,45 | 666,20k | - |
| 2026-04-22 | Atlas Venture Advisors, Inc.Société | -100,00 | 9,01k | Automatic Disposition | 90,08 | 4,57M | -0,00% |
| 2026-04-22 | Dr. Bruce L. BoothCo-Founder & Independent Chairman | -5,90k | 445,59k | Derivative Exercise and Sale | 14,18 - 89,96 | 0,00 | - |
| 2026-04-22 | Dr. Jeremy G. ChadwickCOO | -300,00 | 15,28k | Derivative Exercise and Sale | 30,17 - 90,00 | 15,01k | - |
| 2026-04-14 | Mr. Noah GoodmanChief Business Officer | -1,35k | 121,23k | Automatic Disposition | 90,00 | 50,20k | -2,61% |
| 2026-04-14 | Dr. Jeremy G. ChadwickCOO | -6,55k | 364,16k | Derivative Exercise and Sale | 30,17 - 90,00 | 15,01k | - |
| 2026-04-15 | Atlas Venture Advisors, Inc.Société | -3,14k | 282,46k | Automatic Disposition | 90,10 | 4,57M | -0,07% |
| 2026-04-14 | Dr. Bruce L. BoothCo-Founder & Independent Chairman | -6,36k | 481,90k | Derivative Exercise and Sale | 14,18 - 89,97 | 0,00 | - |
| 2026-04-09 | Mr. Noah GoodmanChief Business Officer | -2,50k | 163,92k | Derivative Exercise and Sale | 21,05 - 86,62 | 4,82k | - |
| 2026-04-09 | Mr. Noah GoodmanChief Business Officer | -3,26k | 284,04k | Vente | 86,62 - 87,11 | 4,82k | -40,39% |
| 2026-04-09 | Mr. Noah GoodmanChief Business Officer | -4,50k | 397,20k | Automatic Disposition | 87,35 - 89,00 | 4,82k | -48,30% |
| 2026-03-31 | Ms. Elena H. RidloffIndependent Director | -12,00k | 854,50k | Derivative Exercise and Sale | 14,18 - 86,05 | 0,00 | - |
| 2026-03-31 | Dr. Jeremy G. ChadwickCOO | -22,24k | 1,24M | Derivative Exercise and Sale | 29,64 - 86,05 | 19,15k | - |
| 2026-03-23 | Dr. Jeremy G. ChadwickCOO | -109,13k | 5,27M | Derivative Exercise and Sale | 29,64 - 80,26 | 19,15k | - |
| 2026-03-23 | Dr. Jeremy G. ChadwickCOO | -6,85k | 547,33k | Automatic Disposition | 79,87 - 80,05 | 19,15k | -26,34% |
| 2026-03-20 | Dr. Pamela EspositoIndependent Director | -2,50k | 75,13k | Derivative Exercise and Sale | 49,10 - 79,94 | 0,00 | - |
| 2026-03-11 | Dr. Jeremy G. ChadwickCOO | -20,00k | 793,62k | Derivative Exercise and Sale | 43,50 - 83,72 | 17,67k | - |
| 2026-03-11 | Dr. Jeremy G. ChadwickCOO | -5,76k | 482,06k | Automatic Disposition | 83,72 | 17,67k | -24,58% |
| 2026-03-02 | Mr. Bruce N. JacobsCFO | -12,47k | 1,09M | Vente | 84,00 - 89,66 | 174,52k | -6,67% |
| 2026-03-02 | Dr. Jared A. GollobChief Medical Officer | -10,51k | 916,67k | Vente | 84,00 - 89,66 | 71,36k | -12,84% |
| 2026-03-02 | Dr. Jeremy G. ChadwickCOO | -5,96k | 515,59k | Vente | 84,00 - 89,66 | 23,43k | -20,28% |
| 2026-03-02 | Atlas Venture Advisors, Inc.Société | -81,87k | 7,38M | Automatic Disposition | 90,13 | 4,58M | -1,76% |
| 2026-02-25 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 2,65M | Derivative Exercise and Sale | 2,08 - 93,49 | 666,20k | - |
| 2026-02-20 | Dr. Pamela EspositoIndependent Director | -2,50k | 95,52k | Derivative Exercise and Sale | 49,10 - 88,10 | 0,00 | - |
| 2026-01-20 | Dr. Pamela EspositoIndependent Director | -5,50k | 157,17k | Derivative Exercise and Sale | 31,20 - 68,52 | - | - |
| 2026-01-05 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | 3,12k | 99,99k | Derivative Exercise and Retained Stock | 32,07 | 666,20k | 0,47% |
| 2025-12-31 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 2,28M | Derivative Exercise and Sale | 2,08 - 78,52 | 663,08k | - |
| 2025-12-17 | Dr. Pamela EspositoIndependent Director | -27,56k | 1,22M | Derivative Exercise and Sale | 27,67 - 84,07 | 0,00 | - |
| 2025-12-17 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | 2,60k | 99,99k | Derivative Exercise and Retained Stock | 38,53 | 663,08k | 0,39% |
| 2025-12-10 | Atlas Venture Advisors, Inc.Société | -236,59k | 21,70M | Vente | 88,64 - 93,20 | 4,66M | -4,83% |
| 2025-12-11 | Baker Bros. Advisors LPSociété | 2,01M | 172,50M | Achat | 86,00 | 8,66M | 30,16% |
| 2025-12-08 | Mr. Jeffrey W. AlbersIndependent Director | -5,00k | 377,92k | Derivative Exercise and Sale | 14,18 - 90,30 | - | - |
| 2025-12-08 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -100,00k | 8,71M | Derivative Exercise and Sale | 2,08 - 89,17 | 660,48k | - |
| 2025-12-08 | Dr. Jared A. GollobChief Medical Officer | -49,31k | 4,11M | Derivative Exercise and Sale | 5,33 - 92,19 | 57,49k | - |
| 2025-10-29 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 1,77M | Derivative Exercise and Sale | 2,08 - 61,46 | 660,48k | - |
| 2025-10-15 | Dr. Jared A. GollobChief Medical Officer | -51,21k | 3,05M | Derivative Exercise and Sale | 1,31 - 62,72 | 57,49k | - |
| 2025-10-15 | Dr. Jared A. GollobChief Medical Officer | -8,37k | 527,15k | Automatic Disposition | 62,72 - 63,09 | 57,49k | -12,70% |
| 2025-10-13 | Dr. Jared A. GollobChief Medical Officer | -1,47k | 85,93k | Derivative Exercise and Sale | 1,31 - 60,00 | 65,86k | - |
| 2025-10-13 | Dr. Jared A. GollobChief Medical Officer | -1,64k | 98,46k | Automatic Disposition | 60,00 | 65,86k | -2,43% |
| 2025-10-13 | Mr. Jeffrey W. AlbersIndependent Director | -5,00k | 244,25k | Derivative Exercise and Sale | 10,34 - 59,19 | 0,00 | - |
| 2025-09-17 | Mr. Bruce N. JacobsCFO | -79,22k | 3,80M | Derivative Exercise and Sale | 2,08 - 50,00 | 168,66k | - |
| 2025-09-16 | Dr. Nello MainolfiCo-Founder, President, CEO & Director | -30,00k | 1,41M | Derivative Exercise and Sale | 2,08 - 49,00 | 660,48k | - |
| 2025-06-30 | BVF Partners L.P.Société | 317,17k | 13,96M | Achat | 44,00 | 5,48M | 6,14% |
| 2025-06-30 | Baker Bros. Advisors LPSociété | 655,50k | 0,00 | Open Market Derivative Acquisition | 0,00 | 10,23M | 6,85% |
| 2025-06-30 | Baker Bros. Advisors LPSociété | 655,50k | 28,84M | Achat | 44,00 | 6,65M | 10,93% |
| 2025-06-11 | Ms. Elena H. RidloffIndependent Director | -4,50k | 133,70k | Derivative Exercise and Sale | 20,29 - 50,00 | 0,00 | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
